Back to Browse Journals » Journal of Pain Research » Volume 6

Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells

Authors Keppel Hesselink JM, Kopsky DJ

Published Date March 2013 Volume 2013:6 Pages 239—245


Received 6 January 2013, Accepted 12 February 2013, Published 21 March 2013

Supplementary video: 42417

Views: 386

Jan M Keppel Hesselink,1 David J Kopsky2

1Institute for Neuropathic Pain, Bosch en Duin, The Netherlands; 2Institute for Neuropathic Pain, Amsterdam, The Netherlands

Abstract: Chronic regional pain syndrome (CRPS) can be intractable to treat and patients sometimes suffer for many years. Therefore, new treatment strategies are needed to alleviate symptoms in CRPS patients. This case report describes a patient suffering from intractable CRPS type 1 for 13 years. Due to her swollen painful feet and left knee she is wheelchair-bound. The combination of palmitoylethanolamide and ketamine 10% cream reduced her pain by more than 50% after 1 month of treatment, and a marked reduction in swelling and skin discoloration was noticed. Furthermore, she could walk independently again and she experienced no side effects. Thus, palmitoylethanolamide and topical ketamine could be a combination therapy option for treating CRPS patients.

Keywords: palmitoylethanolamide, ketamine, cream, CRPS, endocannabinoid, sudeck, mast cells

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Multidisciplinary pain management programs

Kaiser U, Arnold B, Pfingsten M, Nagel B, Lutz J, Sabatowski R

Journal of Pain Research 2013, 6:355-358

Published Date: 8 May 2013

Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study

Bateman L, Palmer RH, Trugman JM, Lin Y

Journal of Pain Research 2013, 6:311-318

Published Date: 26 April 2013

Complementary and alternative exercise for fibromyalgia: a meta-analysis

Mist SD, Firestone KA, Jones KD

Journal of Pain Research 2013, 6:247-260

Published Date: 27 March 2013

Sex differences in the relationship between maternal fear of pain and children's conditioned pain modulation

Evans S, Seidman LC, Lung KC, Zeltzer LK, Tsao JC

Journal of Pain Research 2013, 6:231-238

Published Date: 20 March 2013

Comparison of the transport of QX-314 through TRPA1, TRPM8, and TRPV1 channels

Nakagawa H, Hiura A

Journal of Pain Research 2013, 6:223-230

Published Date: 16 March 2013